AdvisorNet Financial »

Peregrine Pharmaceuticals shares owned by AdvisorNet Financial

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by AdvisorNet Financial from 13F filings

Historical chart of AdvisorNet Financial investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by AdvisorNet Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by AdvisorNet Financial

Quarter filed Position value Share count Share price at filing
2024-03-31 $221 33 6.70
2023-12-31 $215 33 6.52

More positions owned by AdvisorNet Financial

Goldman Sachs Activebeta U.s. Large Cap Equity Etf Etf (GSLC)
Spdr Portfolio S&p 500 Etf Etf (SPLG)
Microsoft Stock (MSFT)
Vanguard Total Stock Market Etf Etf (VTI)
Ishares S&p 500 Index Etf (IVV)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Apple Stock (AAPL)
Schwab Us Dividend Equity Etf Etf (SCHD)
Dimensional U.s. Small Cap Etf Etf (DFAS)
Dimensional Us Core Equity Market Etf Etf (DFAU)
Ishares Aggregate Bond Etf Etf (AGG)
Spdr S&p 500 Etf Etf (SPY)
Vanguard Growth Etf Etf (VUG)
Ishares Dj Us Technology Etf (IYW)
Schwab Short Term Us Treasury Etf Etf (SCHO)

View all positions for AdvisorNet Financial

Top funds holding Peregrine Pharmaceuticals

Millennium Management
Vanguard Group
AltraVue Capital
Royal Bank of Canada
Palisade Capital Management
Wellington Management Company
Punch & Associates Investment Management
AWM Investment Company
Kornitzer Capital Management
New York State Common Retirement Fund
Dimensional Fund Advisors
Sargent Investment Group
Goldman Sachs Group
B. Riley Asset Management
Two Sigma Investments

View all funds holding Peregrine Pharmaceuticals